TCF19 drives a broad transcriptional program that potentiates optimal innate and adaptive functions of antiviral NK cells

Celeste Dang(Memorial Sloan Kettering Cancer Center), Joseph C. Sun(Memorial Sloan Kettering Cancer Center), Rebecca B. Delconte(Memorial Sloan Kettering Cancer Center), Endi K. Santosa(Memorial Sloan Kettering Cancer Center), Alexander Settle(Memorial Sloan Kettering Cancer Center), Hyunu Kim(Memorial Sloan Kettering Cancer Center), Morgan Huse(Memorial Sloan Kettering Cancer Center)
Nature Immunology
August 8, 2025
Cited by 2


Related Papers